Impact of early PCSK9 inhibitor treatment on heart after percutaneous coronary intervention in patients with STEMI: Design and rationale of the PERFECT II trial

BACKGROUND AND AIMS: Primary percutaneous coronary intervention (PPCI) is the most effective treatment strategy for ST-segment elevation myocardial infarction (STEMI). Nevertheless, dysregulated inflammation induced by myocardial reperfusion injury may increase the final infarct size and induce mala...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Jiachun, Wang, Xinyue, Zhou, Jun, Wang, Dong, Pang, Yanan, Xu, Xin, Sang, Zhenchi, Zhang, Yi, Zhang, Junfeng, Wu, Sicheng, Xiao, Zhengguang, Hou, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540492/
https://www.ncbi.nlm.nih.gov/pubmed/36211588
http://dx.doi.org/10.3389/fcvm.2022.1009674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540492/
https://www.ncbi.nlm.nih.gov/pubmed/36211588
http://dx.doi.org/10.3389/fcvm.2022.1009674

Ejemplares similares